EN PL

FDA: Presenting Risk Information in Prescription Drug and Medical Device Promotion

27.05.2009
This guidance responds to stakeholder requests for specific guidance on how FDA evaluates prescription drug and medical device promotional pieces to determine whether they adequately present risk information. The recommendations contained in this draft guidance apply to promotional materials directed to both consumers and healthcare professionals.